This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Aragon Pharmaceuticals, Inc., Janssen Pharmaceutica Nv. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Johny Bertels
Introduction
Johny Bertels is a notable inventor based in Mol, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a total of 2 patents to his name, Bertels has focused on developing innovative solutions for patients suffering from androgen receptor-related diseases.
Latest Patents
Bertels' latest patents include groundbreaking work on anticancer compositions. One of his inventions concerns pharmaceutical formulations of apalutamide, which can be administered to mammals, especially humans, suffering from conditions like prostate cancer. Another significant patent involves the treatment of prostate cancer using a combination of abiraterone acetate, niraparib tosylate monohydrate, and prednisone. This patent outlines both free-dose and fixed-dose combinations of these compounds, providing new methods for treating prostate cancer.
Career Highlights
Throughout his career, Johny Bertels has worked with prominent companies in the pharmaceutical industry. He has been associated with Janssen Pharmaceutica and Aragon Pharmaceuticals, where he contributed to the development of innovative cancer treatments. His work has had a meaningful impact on the lives of many patients.
Collaborations
Bertels has collaborated with several professionals in his field, including Philip Erna H Heyns and Thomas Ronald A Quinten. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Johny Bertels is a dedicated inventor whose work in cancer treatment has the potential to change lives. His innovative patents and collaborations reflect his commitment to advancing medical science.